Ignite Creation Date:
2025-12-24 @ 3:24 PM
Ignite Modification Date:
2025-12-28 @ 11:31 PM
Study NCT ID:
NCT01693692
Status:
COMPLETED
Last Update Posted:
2022-03-04
First Post:
2012-09-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Sponsor:
Theravance Biopharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-11
Start Date Type:
ACTUAL
Primary Completion Date:
2014-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-04
Completion Date Type:
ACTUAL
First Submit Date:
2012-09-20
First Submit QC Date:
None
Study First Post Date:
2012-09-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-02-09
Results First Submit QC Date:
None
Results First Post Date:
2022-03-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-09-13
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-02-09
Last Update Post Date:
2022-03-04
Last Update Post Date Type:
ACTUAL